Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Rat iNOS ELISA Kit (AC2996)
Cat.#: ASET-1585
Specifications
Description Rat iNOS ELISA Kit allows for the in vitro quantitative determination of rat iNOS concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2054 Mouse Nestin ELISA Kit (AC3465) Quantitative inquiry ASET-2312 Human Pannexin 1 ELISA Kit (AC3723) Quantitative inquiry ASET-1944 Human ATP7A ELISA Kit (AC3355) Quantitative inquiry ASET-1007 Human MT3 ELISA Kit (AC2418) Quantitative inquiry ASET-2111 Rat FADS2 ELISA Kit (AC3522) Quantitative inquiry ASET-2363 Human GFAP ELISA Kit (AC3774) Quantitative inquiry ASET-2201 Rat LC3B ELISA Kit (AC3612) Quantitative inquiry ASET-1730 Human Caspase-12 ELISA Kit (AC3141) Quantitative inquiry ASET-1755 Human NK-2R ELISA Kit (AC3166) Quantitative inquiry ASET-1239 Mouse AGRP ELISA Kit (AC2650) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket